Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers — Stella
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(2 sites) United States
Floridian Clinical Research LLC, Miami Lakes, Florida India
Synergen Bio Pvt. Ltd., Pune, Maharashtra
Key details Sponsor
Kashiv BioSciences, LLC
Collaborators
Eric Solutions LLC, Clinexcel Research, Ahmedabad, India
Enrollment target
~40 participants
Primary completion
May 2026
Last updated February 2026